Novo Nordisk (DE:NOV)
XETRA:NOV
Holding DE:NOV?
Track your performance easily

Novo Nordisk (NOV) Financial Statements

170 Followers

Novo Nordisk Financial Overview

Novo Nordisk's market cap is currently ―. The company's EPS TTM is €2.7; its P/E ratio is 38.03; and it has a dividend yield of 1.27%. Novo Nordisk is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is €0.80. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenuekr 65.86Bkr 53.37B-kr 45.57Bkr 41.27B
Gross Profitkr 55.85Bkr 45.19B-kr 38.37Bkr 35.20B
EBIT---kr 21.76Bkr 20.05B
EBITDA---kr 23.80Bkr 21.68B
Net Income Common Stockholderskr 21.96Bkr 19.81B-kr 14.40Bkr 13.32B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 30.23Bkr 27.77Bkr 23.57Bkr 37.47Bkr 31.04B
Total Assetskr 314.49Bkr 250.03Bkr 241.26Bkr 242.84Bkr 218.93B
Total Debtkr 27.01Bkr 25.52Bkr 25.78Bkr 25.97Bkr 25.43B
Net Debtkr -3.22Bkr -2.25Bkr 2.21Bkr -11.50Bkr -5.60B
Total Liabilitieskr 377.58Bkr 170.15Bkr 157.77Bkr 166.16Bkr 144.48B
Stockholders Equitykr 106.56Bkr 79.87Bkr 83.49Bkr 76.68Bkr 74.45B
Cash Flow-
Free Cash Flowkr -6.88Bkr 25.01B-kr 20.01Bkr 21.39B
Operating Cash Flowkr 9.55Bkr 29.81B-kr 24.24Bkr 23.96B
Investing Cash Flowkr -14.72Bkr -6.65B-kr -4.96Bkr -4.20B
Financing Cash Flowkr -10.12Bkr -20.62B-kr -14.56Bkr -10.43B
Currency in DKK

Novo Nordisk Earnings and Revenue History

Novo Nordisk Debt to Assets

Novo Nordisk Cash Flow

Novo Nordisk Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis